Clinical Trials
17 trialsNCT07303816 2026-06-01
STAT-CAT
Brigham and Women's Hospital
Phase 4 Not yet recruiting
NCT07504198 2026-03-31
Neuroprotection of Memantine and Rosuvastatin
Tanta University
Phase 2/3 Not yet recruiting
NCT07254221 2025-12-10
ROSUBREAST
Shiraz University of Medical Sciences
Phase 4 Not yet recruiting
NCT04491643 2025-08-11
Megestrol Acetate Plus Rosuvastatin in Young Women With Early Endometrial Carcinoma
Fudan University
Phase 2 Completed
NCT06102863 2025-04-29
Progesterone Therapeutic Regimen Plus Statins in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia
Peking University People's Hospital
Phase 2 Recruiting
NCT04542382 2025-03-30
BCRPmarker
University of California, San Francisco
Phase 1 Completed
NCT03127631 2025-01-31
RADICALPC
McMaster University
Phase NA Recruiting
NCT03532139 2025-01-23
Pilot Study of Rosuvastatin and Enoxaparin Thromboprophylaxis Following Ovarian Cancer Surgery (O-STAT Study)
Beth Israel Deaconess Medical Center
Phase 2 Completed
NCT05338723 2024-02-28
Possible Protective Effect of Rosuvastatin in Chemotherapy-induced Cardiotoxicity in HER2 Positive Breast Cancer Patients
Tanta University
Phase 3 Completed
NCT02569645 2022-07-20
Rosuvastatin in the Treatment of Rectal Cancer
AHS Cancer Control Alberta
Phase 2 Completed
NCT04776889 2021-03-02
The Prognosis of Lipid Reprogramming With Rosuvastatin, in Castrated Egyptian Prostate Cancer Patients
National Cancer Institute, Egypt
Phase 4 Completed
NCT00966472 2020-04-21
Phase I Study of a Statin + Erlotinib for Advanced Solid Malignancies With Focus on Squamous Cell Carcinomas and NSCLC
Ottawa Hospital Research Institute
Phase 1 Completed
NCT01299038 2020-02-05
Rosuvastatin to Lower Circulating Tissue Factor Bearing Microparticles in Metastatic Breast Cancer
Dana-Farber Cancer Institute
Phase 2 Completed
NCT02114697 2018-09-11
Accelerated Atherosclerosis in High Risk Population Groups: An Assessment by Magnetic Resonance Imaging
Emory University
Phase 4 Terminated
NCT01051401 2018-08-01
Rosuvastatin in Treating Women With Cardiovascular Complications Who Are Undergoing Chemotherapy For Breast Cancer
Wake Forest University Health Sciences
Phase 1 Terminated
NCT01524653 2018-07-10
DISOLVE
University of Vermont
Phase 2 Completed
NCT02483871 2017-06-05
Dose Optimization of Rosuvastatin in Early Stage and Metastatic Estrogen Receptor Positive Breast Cancer Patients on Endocrine Therapy
Duke University
Phase 1 Withdrawn